Find disease awareness content and relevant supporting materials
Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients (mSOMS)
The investigators hypothesize that by applying a validated algorithm to accomplish early mobilization in surgical intensive care unit (ICU) patients, these patients will achieve a higher level of mobility...
A pilot, exploratory, randomized, phase 2 safety study evaluating tumor cell (plasma cell) mobilization and apheresis product contamination in plerixafor plus non-pegylated G-CSF mobilized patients and in non-pegylated G-CSF alone mobilized patients
To evaluate tumor cell mobilization (TCM) with non-pegylated G-CSF alone compared with non pegylated G-CSF plus plerixafor in patients with...
BL 8040 filed with FDA for stem cell mobilization for autologous bone marrow transplantation for multiple myeloma.
BioLineRx announced that the Company has submitted its New Drug Application (NDA) to the FDA for BL 8040 (motixafortide) in stem cell mobilization (SCM) for autologous bone marrow transplantation for multiple myeloma patients.